Collegium Pharmaceutical, Inc. (COLL)
NASDAQ: COLL · Real-Time Price · USD
36.08
-0.19 (-0.52%)
Jul 17, 2026, 4:00 PM EDT - Market closed
Collegium Pharmaceutical Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $56 | Buy | Maintains | $56 | +55.21% | Jul 1, 2026 |
| Truist Financial | Truist Financial | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 15, 2026 |
| Needham | Needham | Buy Maintains $56 | Buy | Maintains | $56 | +55.21% | May 12, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $60 | Buy | Reiterates | $60 | +66.30% | May 8, 2026 |
| Piper Sandler | Piper Sandler | Hold Maintains $44 | Hold | Maintains | $44 | +21.95% | Apr 23, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $51 | Buy | Maintains | $51 | +41.35% | Mar 20, 2026 |